Skip to main content

Table 2 Echocardiographic parameters of patients and controls

From: Tissue doppler echocardiography detects preclinical markers of cardiac lesion in MDS patients

 

Controls(14)

NT-MDS(21)

T-MDS(13)

P value

Baseline demographics and characteristics

   

Age (year)

72.4 ± 8 (58–84)

70.3 ± 14 (47–88)

65.2 ± 20 (27–90)

NS

Gender (m/f)

(6/8)

(7/14)

(6/7)

 

Body weigth (kg)

66.0 ± 11.9 (46 – 83)

63.7 ± 10.1 (43.6 – 91.3)

64.9 ± 10.1 (49.3 – 90)

NS

Height (m)

1.59 ± 0.09 (1.45 – 1.75)

1.57 ± 0.07 (1.46 – 1.72)

1.59 ± 0.08 (1.45 – 1.70)

NS

BSA (m 2 )

1.68 ± 0.16 (1.42 – 1.98)

1.64 ± 0.15 (1.33 – 2.01)

1.67 ± 0.15 (1.4 – 2.01)

NS

BMI (kg/m 2 )

26.2 ± 5.7 (19.1 – 36.9)

25.8 ± 2.9 (20.5 – 32.3)

25.5 ± 3.7 (21.4 – 32.7)

NS

HR (bpm)

75.8 ± 5.4 (66–83)

77.6 ± 1.4 (66–88)

78.4 ± 2.2(65–90)

NS

SBP (mmHg)

 

139.2 ± 19 (110–180)

121.8 ± 16 (100–150)

<0.02

DBP (mmHg)

 

77.9 ± 12 (60–108)

70 ± 9.6 (60–90)

NS

Hb (g/dL)

 

9.85 ± 1.8 (6.6 - 12.7)

6.5 ± 1.7 (3.8 - 9.9)

<0.001

Ferritin (ng/mL)

 

298.8 ± 234 (22.4 a 850)

2269 ± 1931 (223 a 7101)

<0.001

Chamber quantification and ejection fraction of patients and controls

   

LVDD (mm)

46.0 ± 4.7 (40–57)

48.5 ± 3.9 (41–56)

49.3 ± 6.6 (40–64)

NS

LVSD (mm)

26.9 ± 4.9 (19–39)

27.7 ± 3.7 (22–37)

29.5 ± 6.8 (23–50)

NS

IVS (mm)

8.9 ± 2.3 (6–16)

8.5 ± 0.9 (7–11)

8.9 ± 1.4 (7–12)

NS

LVPW (mm)

8.5 ± 1.7 (6–13)

8.4 ± 0.7 (7–10)

8.8 ± 1.4 (7–12)

NS

MASS (g)

165.9 ± 61,0 (79–326)

173.8 ± 34.1 (116–249)

165.9 ± 61.0 (90–321)

NS

MASS index (g/m 2 )

101.3 ± 37 (55.6 - 185)

106 ± 18 (73–140.7)

110 ± 37.1 (56.2 - 198)

NS

EF%TEI

71.8 ± 7.6 (58.2 - 89)

71.9 ± 6.5 (58.8 - 80.1)

69.8 ± 9.3 (43.6 - 83.9)

NS

FS (%)

41.4 ± 6.8 (31.2 - 58)

41.6 ± 5.7 (31–48.7)

39.4 ± 7.2 (22–53)

NS

LA (mm)

32 ± 4.2 (27–44)

33.4 ± 4.2 (28–43)

36.5 ± 4.9 (31–46)

<0.04*

EF%SIM

67.7 ± 7.3 (50.1 - 81.3)

66.2 ± 4.8 (55.2 - 76.1)

64.7 ± 5.4 (50.7 - 70.8)

NS

LVEDV (ml)

65.5 ± 18 (37–105)

85.1 ± 29.9 (44–169)

92.8 ± 36.1 (49–189)

<0.05*

LVESV (ml)

20.5 ± 6.2 (10–28)

28.7 ± 11.9 (12.5 - 65)

33.8 ± 19.7 (15–93)

<0.04*

LAV (ml)

39.1 ± 14.5 (17–69)

43.5 ± 10.3 (25–64)

59.8 ± 24.8 (29–120)

<0.006**

LAV index (mL/m 2 )

22.8 ± 8 (10.5 - 39.6)

26.5 ± 5.2 (15.9 - 34.8)

35.9 ± 15 (18.8 - 70.9)

<0.004**

Doppler parameters (transmitral and myocardial tissue) and strain of patients and controls

Evel(cm/s)

77.2 ± 13.2 (55.4 - 105)

89.6 ± 20 (63–128)

96.6 ± 14.2 (68.5 - 116)

<0.02*

Avel(cm/s)

94.3 ± 18 (68.6 - 137.3)

100.2 ± 19 (68.5 - 131)

100.6 ± 27 (52.8 - 145)

NS

E/A

0.83 ± 0.2 (0.6 - 1.2)

0.9 ± 0.2 (0.6 - 1.4)

1.0 ± 0.26 (0.64 - 1,6)

NS

Em(cm/s)

8.6 ± 3.2 (4.1 - 14)

9.3 ± 2.4 (5.4 - 14)

10.4 ± 2.5 (7.5 a 14.8)

NS

E/Em

10 ± 3.4 (5.3 - 16.2)

10.3 ± 3,9 (5.6 - 20)

9.7 ± 2.9 (5.9 - 14.4)

NS

LV-Sm(cm/s)

6.5 ± 1.3 (5.1 - 9.5)

7.9 ± 1.3 (5.5 - 10.8)

7.8 ± 1.3 (6–10,3)

<0.02*

RV-Sm(cm/s)

10.1 ± 0.7 (9.1 - 11)

11.4 ± 3.3 (7.6 - 19)

12.3 ± 1,5 (9.8 - 14,7)

NS

TAPSE(mm)

24.9 ± 4.2 (20–33)

28.2 ± 5.3 (21–39)

28.9 ± 5 (22–40)

NS

VD basal(mm)

30.1 ± 6.4 (22–48)

31.7 ± 4 (24–41)

31.5 ± 4 (23–39)

NS

ST2DL (%)

−19.9 ± 2.7 (−24 to −13)

−20.7 ± 2.5 (−25 to −16,8)

−20.9 ± 1.4 (−23 to - 18,6)

NS

  1. Legend. NT-MDS: non-transfused patients; T-MDS: transfused patients; LVDD: left ventricular diastolic diameter; LVSD: left ventricular systolic diameter; IVS: inter-ventricular septum; LVPW: left ventricular posterior wall; MASS: left ventricular mass; EF%TEI: ejection fraction Teicholz; FS: fractional shortening; LA: left atrial diameter; EF%SIM: ejection fraction Simpson; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; LAV: left atrial volume.